U.S. scientists helped devise the Crispr biotechnology tool that has captured global attention for its potential to treat incurable diseases. The first to test it in humans are Chinese doctors, who don’t face the same regulatory hurdles as American counterparts.
from WSJ.com: US Business http://ift.tt/2Dv81tr
via IFTTT
No comments:
Post a Comment